Novartis Venture Fund
Terri Gallagher is a seasoned professional in the pharmaceutical sales industry, currently serving as a Neuroscience Executive Sales Specialist at Novartis since April 2022. Prior experience includes roles as a Neuroscience Account Manager at SK Life Science, Inc. from January 2020 to April 2022 and as a Neurology Therapeutic Specialist at Sunovion Pharmaceuticals from September 2017 to January 2020. Gallagher began a successful career in sales with GSK, where a tenure from October 2000 to September 2017 culminated in the position of Senior Pharmaceutical Sales. Gallagher holds a BS in Registered Nursing from the University of Memphis, earned between 1992 and 1998.
This person is not in any teams
This person is not in any offices
Novartis Venture Fund
3 followers
Novartis Venture Fund's primary focus is on the development of novel therapeutics and platforms. In their investments, they look for unmet need and clinical impact, novel proprietary science, and understanding of the mechanism, management, and board experience and capital efficiency in the program.